Changes to gene therapy are successful and safer for children with immune disorder
Changes in the way working genes are delivered to children with SCID (Severe Combined Immunodeficiency) could make gene therapy for the disease even safer, finds research led by a team at Great Ormond Street Hospital (GOSH) and its research partner the UCL Institute of Child Health. Alterations to the delivery method, which are published in […]
